Enveric Biosciences financial statements
엔버릭 바이오사이언시스NASDAQ:ENVB · Nasdaq · Healthcare$1.48+1.37%
2026-10-02 closeEnveric Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$10M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy